Hemels Michiel E H, Einarson Adrienne, Koren Gideon, Lanctôt Krista L, Einarson Thomas R
Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Ann Pharmacother. 2005 May;39(5):803-9. doi: 10.1345/aph.1E547. Epub 2005 Mar 22.
Due to the high prevalence of depression in women of childbearing age and coupled with the fact that approximately 50% of the pregnancies are unplanned, there is a high chance that these women have been exposed to antidepressants in early pregnancy.
To determine baseline rates of spontaneous abortions (SAs) and whether antidepressants increase those rates.
Rates of SAs in women taking antidepressants compared with non-depressed women were combined into a relative risk using a random effects model. MEDLINE, EMBASE, Healthstar, Toxline, Psychlit, Cochrane database, and Reprotox were searched for studies published in any language from 1966 to 2003. Key words used to identify articles included pregnancy outcome, abortion, miscarriage, spontaneous, antidepressant, depression, and the generic names of each antidepressant and class. Bibliographies, review articles, and reference lists from studies were also used to identify potential articles expected to provide evidence of safety of antidepressants in pregnancy.
Of 15 potential articles, 6 cohort studies of 3567 women (1534 exposed, 2033 nonexposed) provided extractable data. All matched on important confounders. Tests found no heterogeneity (chi2 3.13; p = 0.98), and all quality scores were adequate (>50%). The baseline SA rate (95% CI) was 8.7% (7.5% to 9.9%; n = 2033). For antidepressants, the rate was 12.4% (10.8% to 14.1%; n = 1534), significantly increased by 3.9% (1.9% to 6.0%); RR was 1.45 (1.19 to 1.77; n = 3567). No differences were found among antidepressant classes.
Maternal exposure to antidepressants may be associated with increased risk for SA; however, depression itself cannot be ruled out.
由于育龄女性中抑郁症的高患病率,再加上约50%的怀孕是意外怀孕,这些女性在怀孕早期接触抗抑郁药的可能性很高。
确定自然流产(SA)的基线发生率以及抗抑郁药是否会增加这些发生率。
使用随机效应模型将服用抗抑郁药的女性与未患抑郁症的女性的SA发生率合并为相对风险。检索MEDLINE、EMBASE、Healthstar、Toxline、Psychlit、Cochrane数据库和Reprotox,查找1966年至2003年以任何语言发表的研究。用于识别文章的关键词包括妊娠结局、流产、自然流产、抗抑郁药、抑郁症以及每种抗抑郁药及其类别名称。研究的参考文献、综述文章和参考文献列表也用于识别预期能提供抗抑郁药在孕期安全性证据的潜在文章。
在15篇潜在文章中,6项队列研究涉及3567名女性(1534名暴露,2033名未暴露),提供了可提取的数据。所有研究都对重要混杂因素进行了匹配。检验发现无异质性(卡方值3.13;p = 0.98),且所有质量评分均足够(>50%)。基线SA发生率(95%可信区间)为8.7%(7.5%至9.9%;n = 2033)。对于抗抑郁药,发生率为12.4%(10.8%至14.1%;n = 1534),显著增加了3.9%(1.9%至6.0%);相对风险为1.45(1.19至1.77;n = 3567)。抗抑郁药类别之间未发现差异。
母亲接触抗抑郁药可能与SA风险增加有关;然而,不能排除抑郁症本身的影响。